NCT00199160View on ClinicalTrials.gov

Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Head and Neck Neoplasms
Interventions
DRUG

BAY 43-9006

Trial Locations (1)

1000

Jules Bordet Institute, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER